Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05820243
Other study ID # 1783804
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 12, 2023
Est. completion date September 2024

Study information

Verified date November 2023
Source University of Delaware
Contact David Edwards, PhD
Phone 302-831-3363
Email dge@udel.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this study is to learn about how blood vessel dilation after exercise effects pulse wave reflection and influences the function of the heart in healthy young adults. The main question it aims to answer is: Are post-exercise decreases in reflected pulse waves due to a decrease in the stiffness of large arteries in the leg or an increase in leg blood flow? Participants will exercise on a stationary bicycle at a moderate intensity for 1 hour during two laboratory visits. Participants will take oral antihistamines to block post-exercise dilation at one visit, and they will take placebo pills at the other visit. At both visits, leg blood flow, pulse wave velocity, and heart function will be measured before exercise and for 120-minutes after exercise.


Description:

During exercise, blood vessels increase in size to supply muscles with more blood. After exercise, the muscles that had been used release chemicals called histamines that cause the blood vessels to stay dilated even when the muscles no longer need more blood. It takes around 2 hours for the blood vessels to return to normal. This causes blood pressure to be lower than it usually is at rest. This phenomenon delays the return of pressure waves in arteries that are reflected back to the heart resulting in the heart having to work less hard to pump out blood for about 2 hours after exercise. However, it is unknown why the reflected pressure waves return to the heart later. The aim of this study is to determine if this delay is due to the speed of the reflected waves being slowed by large arteries or dilation of small arteries resulting in the reflections originating further from the heart. By giving antihistamines prior to exercise, post-exercise blood vessel dilation of the small arteries will be largely reduced, thus allowing for the determination of which factor causes the reflected waves to return later. Additionally, it is hypothesized that the reduction in work that the heart must perform results in improved contraction and relaxation of the heart. Thus, an additional aim is to determine how post-exercise blood vessel dilation influence heart function. To accomplish these aims, blood flow leaving the left ventricle and femoral blood flow will be measured via Doppler ultrasound. Applanation tonometry will be used to record pulse waves at the carotid, radial, femoral, and dorsalis pedis arteries. These pulse waves will be used to estimate central blood pressure and to determine pulse wave velocity of different arterial segments. Measurements will be made at baseline and for 120 minutes after a bout of moderate intensity aerobic exercise.


Recruitment information / eligibility

Status Recruiting
Enrollment 25
Est. completion date September 2024
Est. primary completion date April 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - healthy men and women - sedentary or recreationally active Exclusion Criteria: - history of cardiovascular events or procedures - stage 2 hypertension (BP: =140 systolic or =90 diastolic) - metabolic syndrome - renal disease - chronic respiratory disease - currently prescribed any cardiovascular medication - current use of erythromycin and/ ketoconazole - current pregnancy or breastfeeding -hormone replacement therapy- - tobacco use - musculoskeletal injury/disorder that would inhibit cycling exercise - body mass index (BMI) <18.5 or >35kg/m^2 - reduced kidney function (estimated glomerular filtration rate< 90ml/min/1.73 m^2) - daily use of fexofenadine and/or famotidine

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Moderate Intensity Aerobic Exercise
Participants will complete 1 hour of exercise on a cycle ergometer at the power output that elicits 60% of their peak rate of oxygen consumption (V02peak).

Locations

Country Name City State
United States Department of Kinesiology and Applied Physiology, University of Delaware Newark Delaware

Sponsors (1)

Lead Sponsor Collaborator
University of Delaware

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in lower limb arterial stiffness Arterial stiffness of the leg will be assessed via measurement of femoral-pedis pulse wave velocity. 120 minutes post-exercise
Primary Change in leg vascular conductance Vascular conductance, an index of peripheral vasodilation, will be determined by measuring femoral blood flow via ultrasound and dividing by mean arterial pressure. 120 minutes post-exercise
Primary Change in left ventricular pulsatile load Doppler echocardiography and arterial tonometry will be used to establish left ventricular pressure-flow relations. Wave separation analysis will subsequently be performed to determine the magnitude and timing of reflected pulse waves. 120 post-exercise
Secondary Change in left ventricular diastolic function Echocardiographic measures of left ventricular diastolic function will be recorded, including mitral annulus tissue velocity and mitral in-flow velocity 120 minutes post-exercise
See also
  Status Clinical Trial Phase
Completed NCT03957746 - Set Volume of Optimal Resistance Exercise to Generate Hypotension N/A
Completed NCT03565653 - The Effects of Dietary Salt on Post-exercise Hypotension N/A
Completed NCT02335840 - Doses of Coffee and Blood Pressure Response Post-exercise N/A
Completed NCT02650089 - Resistance Exercise Modify Cardiovascular Responses of Professors During Teaching and Sleep N/A
Completed NCT04514354 - The Influence of Cardiorespiratory Fitness on Firefighter Cardiovascular Health Under Exercise Conditions N/A